Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrielle Caussy
Rohit Loomba

Showing results (1-10 of 682) with videos related to

Pageof 69
Sort By:
Current Diabetes Reports|March 20, 2021
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular RiskCyrielle Caussy, Adrien Aubin, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2019
Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver DiseasePaul J Mills, Cyrielle Caussy, Rohit Loomba
Gut|May 9, 2020
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challengesJean-François Dufour, Cyrielle Caussy, Rohit Loomba
Clinics in Liver Disease|May 16, 2026
Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated SteatohepatitisAngelo Armandi, Elisabetta Bugianesi, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)|January 23, 2018
Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH TrialsCyrielle Caussy, Scott B Reeder, Claude B Sirlin, et al.
Hepatology (Baltimore, Md.)|May 9, 2024
Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver diseaseXiaolong Qi, Jie Li, Cyrielle Caussy, et al.
Endocrinology, Diabetes & Metabolism|October 26, 2020
Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitisCyrielle Caussy, Lars Johansson
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2019
Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the StandardCyrielle Caussy, Justine Brissot, Seema Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 DiabetesNeeraj Mangla, Veeral H Ajmera, Cyrielle Caussy, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
Management of obesity in advanced chronic liver diseaseCyrielle Caussy, Sven M Francque
Pageof 69

Showing results (1-10 of 682) with videos related to

Sort By:
Pageof 69
Current Diabetes Reports|March 20, 2021
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular RiskCyrielle Caussy, Adrien Aubin, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2019
Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver DiseasePaul J Mills, Cyrielle Caussy, Rohit Loomba
Gut|May 9, 2020
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challengesJean-François Dufour, Cyrielle Caussy, Rohit Loomba
Clinics in Liver Disease|May 16, 2026
Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated SteatohepatitisAngelo Armandi, Elisabetta Bugianesi, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)|January 23, 2018
Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH TrialsCyrielle Caussy, Scott B Reeder, Claude B Sirlin, et al.
Hepatology (Baltimore, Md.)|May 9, 2024
Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver diseaseXiaolong Qi, Jie Li, Cyrielle Caussy, et al.
Endocrinology, Diabetes & Metabolism|October 26, 2020
Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitisCyrielle Caussy, Lars Johansson
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2019
Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the StandardCyrielle Caussy, Justine Brissot, Seema Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 DiabetesNeeraj Mangla, Veeral H Ajmera, Cyrielle Caussy, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
Management of obesity in advanced chronic liver diseaseCyrielle Caussy, Sven M Francque
Pageof 69